All terms in GO

Label Id Description
amygdala development GO_0021764 [The progression of the amygdala over time from its initial formation until its mature state. The amygdala is an almond-shaped set of neurons in the medial temporal lobe of the brain that play a key role in processing emotions such as fear and pleasure.]
negative regulation of larval salivary gland boundary specification GO_0045710 [Any process that stops, prevents, or reduces the frequency, rate or extent of salivary gland determination in a larval organism.]
limbic system development GO_0021761 [The progression of the limbic system over time from its initial formation until its mature state. The limbic system is a collection of structures in the brain involved in emotion, motivation and emotional aspects of memory.]
substantia nigra development GO_0021762 [The progression of the substantia nigra over time from its initial formation until its mature state. The substantia nigra is the layer of gray substance that separates the posterior parts of the cerebral peduncles (tegmentum mesencephali) from the anterior parts; it normally includes a posterior compact part with many pigmented cells (pars compacta) and an anterior reticular part whose cells contain little pigment (pars reticularis).]
positive regulation of adult salivary gland boundary specification GO_0045711 [Any process that activates or increases the frequency, rate or extent of salivary gland determination in an adult organism.]
cellular response to haloperidol GO_1905120 [Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a haloperidol stimulus.]
obsolete regulation of glucosylceramidase activity GO_1905123 [OBSOLETE. Any process that modulates the frequency, rate or extent of glucosylceramidase activity.]
obsolete negative regulation of glucosylceramidase activity GO_1905124 [OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of glucosylceramidase activity.]
GO_1905121 GO_1905121
GO_1905122 GO_1905122
obsolete regulation of pyrimidine nucleobase metabolic process GO_0006142 [OBSOLETE. Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving pyrimidine nucleobases.]
obsolete purine metabolic process GO_0006143 [OBSOLETE. (Was not defined before being made obsolete).]
fin regeneration GO_0031101 [The regrowth of fin tissue following its loss or destruction.]
adenine catabolic process GO_0006146 [The chemical reactions and pathways resulting in the breakdown of adenine, 6-aminopurine, one of the 5 main bases found in nucleic acids and a component of numerous important derivatives of its corresponding ribonucleoside, adenosine.]
adenine metabolic process GO_0046083 [The chemical reactions and pathways involving adenine, 6-aminopurine, one of the five main bases found in nucleic acids and a component of numerous important derivatives of its corresponding ribonucleoside, adenosine.]
neuron projection regeneration GO_0031102 [The regrowth of neuronal processes such as axons or dendrites in response to their loss or damage.]
guanine catabolic process GO_0006147 [The chemical reactions and pathways resulting in the breakdown of guanine, 2-amino-6-hydroxypurine, a purine that is one of the five main bases found in nucleic acids and a component of a number of phosphorylated guanosine derivatives whose metabolic or regulatory functions are important.]
inosine catabolic process GO_0006148 [The chemical reactions and pathways resulting in the breakdown of inosine, hypoxanthine riboside, a nucleoside found free but not in combination in nucleic acids except in the anticodons of some tRNAs.]
inosine metabolic process GO_0046102 [The chemical reactions and pathways involving inosine, hypoxanthine riboside, a nucleoside found free but not in combination in nucleic acids except in the anticodons of some tRNAs.]
oligodendrocyte cell fate specification GO_0021778 [The process in which a cell becomes capable of differentiating autonomously into an oligodendrocyte in an environment that is neutral with respect to the developmental pathway. Upon specification, the cell fate can be reversed.]